RAI1 Antibodies

Santa Cruz Biotechnology offers a broad range of RAI1 monoclonal antibodies for research focused on understanding RAI1 protein mechanisms. RAI1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). RAI1, or Retinoic Acid Induced 1, plays an essential role in gene regulation and influences various developmental processes. RAI1 functions are particularly significant in neurodevelopment, and mutations in RAI1 have been associated with Smith-Magenis syndrome. Research has shown that RAI1 influences multiple cellular pathways and signaling mechanisms. Understanding RAI1's molecular interactions can reveal important insights about developmental disorders and potential therapeutic approaches. Investigating RAI1 expression patterns helps scientists uncover its role in both normal development and disease states. Ongoing studies of RAI1 continue to reveal new aspects of its biological significance. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of RAI1's role in human health and disease.